Net Cash Provided by (Used in) Operating Activities |
202K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
3.43M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
202K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
10.2M |
USD |
+3.77% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
279K |
USD |
+10.7% |
Q4 2023 |
FY 2023 |
Cash and Cash Equivalents, Period Increase (Decrease) |
891K |
USD |
|
Q1 2022 |
Q1 2022 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
442K |
USD |
+26.6% |
Q3 2024 |
Q3 2024 |
Property, Plant and Equipment, Gross |
2.63M |
USD |
-1.06% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
19K |
USD |
|
Q1 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
24K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
382K |
USD |
+33.6% |
Q4 2023 |
FY 2023 |
Interest Expense |
1K |
USD |
0% |
Q3 2022 |
Q3 2022 |